Table 2.
Symptoms at diagnosis and follow-up consultations.
| Consultation | ||||||
|---|---|---|---|---|---|---|
| COVID diagnosis | First consultation | Second consultation | Third consultation | Fourth consultation | ||
| Count (%) | Count (%) | Count (%) | Count (%) | Count (%) | p a | |
| Headache | 79 (36.7) | 5 (2.3) | 0 | 0 | 1 (0.5) | <0.001 |
| Fever | 133 (61.9) | 3 (1.4) | 0 | 0 | 0 | <0.001 |
| Rhinorrhea | 60 (27.9) | 11 (5.1) | 6 (2.8) | 1 (0.5) | 1 (0.5) | <0.001 |
| Dyspnea | 52 (24.2) | 19 (8.8) | 5 (2.3) | 4 (1.9) | 0 | <0.001 |
| Dry cough | 46 (21.4) | 14 (6.5) | 5 (2.3) | 1 (0.5) | 0 | <0.001 |
| Wet cough | 13 (6) | 4 (1.9) | 1 (0.5) | 0 | 0 | <0.001 |
| Odynophagia | 25 (11.6) | 1 (0.5) | 1 (0.5) | 0 | 0 | <0.001 |
| Desaturation | 37 (17.2) | 3 (1.4) | 2 (0.9) | 0 | 0 | <0.001 |
| Conjunctival injection | 33 (15.3) | 1 (0.5) | 0 | 0 | 0 | <0.001 |
| Chemosis | 3 (1.4) | 0 | 0 | 0 | 0 | 0.358 |
| Epiphora | 6 (2.8) | 1 (0.5) | 0 | 0 | 0 | 0.197 |
| Irritability | 34 (15.8) | 1 (0.5) | 0 | 0 | 0 | <0.001 |
| Abdominal pain | 59 (27.4) | 3 (1.4) | 1 (0.5) | 0 | 0 | <0.001 |
| Diarrhea | 45 (20.9) | 3 (1.4) | 0 | 0 | 0 | <0.001 |
| Nausea and/or vomiting | 42 (19.5) | 2 (0.9) | 1 (0.5) | 0 | 0 | <0.001 |
| Smell alteration | 29 (13.5) | 5 (2.3) | 0 | 0 | 0 | <0.001 |
| Taste alteration | 23 (10.7) | 3 (1.4) | 0 | 0 | 0 | <0.001 |
| Skin alterations | 8 (3.7) | 2 (0.9) | 1 (0.5) | 0 | 0 | 0.306 |
| Vasculitis | 2 (0.9) | 0 | 0 | 0 | 0 | 0.573 |
| Fatigue | 42 (19.5) | 14 (6.5) | 5 (2.3) | 0 | 0 | <0.001 |
| Myalgia | 42 (19.5) | 2 (0.9) | 0 | 1 (0.5) | 0 | <0.001 |
| Paresthesia | 6 (2.8) | 2 (0.9) | 0 | 0 | 0 | 0.364 |
| Rash | 29 (13.5) | 1 (0.5) | 0 | 0 | 0 | <0.001 |
| Joint pain | 23 (10.7) | 6 (2.8) | 0 | 0 | 0 | <0.001 |
a
Chi-square.